{"pmid":32393591,"title":"COVID-19 and lung transplant patients.","text":["COVID-19 and lung transplant patients.","COVID-19 is a novel respiratory disease leading to high rates of acute respiratory failure requiring hospital admission. It is unclear if specific patient populations such as lung transplant patients are at higher risk for COVID-19. Some reports suggest that transplant patients may not be at higher risk if proper social distancing and preventive measures are employed. Efforts to ensure the safety of wait-listed patients, transplant recipients, and healthcare workers are underway. Recommendations for the care of lung transplant patients during the COVID-19 pandemic are discussed and will likely change as the pandemic evolves.","Cleve Clin J Med","Tsuang, Wayne M","Budev, Marie M","32393591"],"abstract":["COVID-19 is a novel respiratory disease leading to high rates of acute respiratory failure requiring hospital admission. It is unclear if specific patient populations such as lung transplant patients are at higher risk for COVID-19. Some reports suggest that transplant patients may not be at higher risk if proper social distancing and preventive measures are employed. Efforts to ensure the safety of wait-listed patients, transplant recipients, and healthcare workers are underway. Recommendations for the care of lung transplant patients during the COVID-19 pandemic are discussed and will likely change as the pandemic evolves."],"journal":"Cleve Clin J Med","authors":["Tsuang, Wayne M","Budev, Marie M"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32393591","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3949/ccjm.87a.ccc004","topics":["Prevention"],"weight":1,"_version_":1666627827904020481,"score":9.490897,"similar":[{"pmid":32357275,"title":"Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.","text":["Strategies for Prevention and Control of the 2019 Novel Coronavirus Disease in the Department of Kidney Transplantation.","OBJECTIVE: To summarize measures for prevention and control of the 2019 novel Corona Virus Disease (COVID-19) in the department of kidney transplantation. METHODS: We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20, 2020 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including: kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, follow-up management of discharged patients after kidney transplantation, etc. RESULTS: During the epidemic period, there were no COVID-19 among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital and 30 medical staff. There were no COVID-19 in the follow-up of 160 recipients after kidney transplantation and 60 patients waiting for kidney transplantation. CONCLUSION: During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure the safe and orderly work of the department.","Transpl Int","Li, Yurong","Yang, Ning","Li, Xiaoxiao","Wang, Junpeng","Yan, Tianzhong","32357275"],"abstract":["OBJECTIVE: To summarize measures for prevention and control of the 2019 novel Corona Virus Disease (COVID-19) in the department of kidney transplantation. METHODS: We retrospectively analyzed the clinical data of outpatients and inpatients in the department of kidney transplantation from January 20, 2020 to March 1, 2020, and followed up the in-home kidney transplant recipients and those waiting for kidney transplantation through the Internet platform. Our department had formulated detailed prevention and control measures, mainly including: kidney transplant outpatient management, kidney transplantation ward management, management of kidney transplant surgery, dialysis management of patients waiting for kidney transplantation, personal protection of medical staff, follow-up management of discharged patients after kidney transplantation, etc. RESULTS: During the epidemic period, there were no COVID-19 among 68 outpatient examined kidney transplant recipients, 32 hospitalized kidney transplant recipients, 19 patients waiting for kidney transplantation in hospital and 30 medical staff. There were no COVID-19 in the follow-up of 160 recipients after kidney transplantation and 60 patients waiting for kidney transplantation. CONCLUSION: During the epidemic period, we implemented strict prevention and control measures and adjusted working methods and procedures to ensure the safe and orderly work of the department."],"journal":"Transpl Int","authors":["Li, Yurong","Yang, Ning","Li, Xiaoxiao","Wang, Junpeng","Yan, Tianzhong"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32357275","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/tri.13634","keywords":["2019 novel coronavirus disease","kidney transplant","pneumonia","prevention and control"],"topics":["Prevention"],"weight":1,"_version_":1666138495198953472,"score":204.25981},{"pmid":32476233,"title":"Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France.","text":["Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France.","Liver transplantation during the ongoing SARS-CoV-2 pandemic is challenging given the urgent need to reallocate resources to other areas of patient care. Available guidelines recommend to reorganize transplant care but data on clinical experience in the context of SARS-CoV-2 pandemic are scarce. Thus, we report strategies and preliminary results in liver transplantation during the peak of the SARS-CoV-2 pandemic from a single-center in France. Our strategy to reorganize the transplant program included four main steps: optimization of available resources especially intensive care unit capacity, multidisciplinary risk stratification of liver transplantation candidates on the waiting list, implementation of a systematic SARS-CoV-2 screening strategy prior to transplantation and definition of optimal recipient-donor matching. After implementation of these four steps, we performed 10 successful liver transplantations during the peak of the pandemic with a short median intensive care unit stay (2,5 days), benchmark post-transplant morbidity and no occurrence of SARS-CoV-2 infection during follow-up. From this preliminary experience we conclude that efforts in resource planning, optimal recipient selection and organ allocation strategy are key to maintain a safe liver transplant activity. Transplant centers should be ready to readapt their practices as the pandemic evolves.","Am J Transplant","Muller, Xavier","Tilmans, Gilles","Chenevas-Paule, Quentin","Lebosse, Fanny","Antonini, Teresa","Poinsot, Domitille","Rode, Agnes","Guichon, Celine M","Schmitt, Zoe","Ducerf, Christian","Mohkam, Kayvan","Lesurtel, Mickael","Mabrut, Jean-Yves","32476233"],"abstract":["Liver transplantation during the ongoing SARS-CoV-2 pandemic is challenging given the urgent need to reallocate resources to other areas of patient care. Available guidelines recommend to reorganize transplant care but data on clinical experience in the context of SARS-CoV-2 pandemic are scarce. Thus, we report strategies and preliminary results in liver transplantation during the peak of the SARS-CoV-2 pandemic from a single-center in France. Our strategy to reorganize the transplant program included four main steps: optimization of available resources especially intensive care unit capacity, multidisciplinary risk stratification of liver transplantation candidates on the waiting list, implementation of a systematic SARS-CoV-2 screening strategy prior to transplantation and definition of optimal recipient-donor matching. After implementation of these four steps, we performed 10 successful liver transplantations during the peak of the pandemic with a short median intensive care unit stay (2,5 days), benchmark post-transplant morbidity and no occurrence of SARS-CoV-2 infection during follow-up. From this preliminary experience we conclude that efforts in resource planning, optimal recipient selection and organ allocation strategy are key to maintain a safe liver transplant activity. Transplant centers should be ready to readapt their practices as the pandemic evolves."],"journal":"Am J Transplant","authors":["Muller, Xavier","Tilmans, Gilles","Chenevas-Paule, Quentin","Lebosse, Fanny","Antonini, Teresa","Poinsot, Domitille","Rode, Agnes","Guichon, Celine M","Schmitt, Zoe","Ducerf, Christian","Mohkam, Kayvan","Lesurtel, Mickael","Mabrut, Jean-Yves"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476233","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ajt.16082","locations":["France","optimal","optimal","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1668437834987470848,"score":197.67752},{"pmid":32457133,"title":"The impact of the COVID-19 pandemic on renal transplantation in the UK.","text":["The impact of the COVID-19 pandemic on renal transplantation in the UK.","COVID-19 is impacting provision of renal transplantation in the UK with a reduction in clinical activity. Publicly available Renal Registry and NHS Blood and Transplant reports were analysed to model the number of missed transplant opportunities, waiting list size and change in dialysis population over a six-month period starting 5 March 2020. An estimated 1,670 kidney transplant opportunities may be lost, which will lead to 6,317 active patients on the kidney-alone waiting list, compared to 4,649 based on usual activity estimates. This will result in 1,324 additional patients on dialysis who would otherwise have been transplanted. COVID-19 will lead to a marked loss of transplant opportunities and a significantly larger national waiting list. The existing strain on dialysis capacity will be exacerbated as patients remain on dialysis as the only available form of renal replacement therapy. These findings will help inform policy and service specific strategies.","Clin Med (Lond)","Sharma, Videha","Shaw, Alex","Lowe, Marcus","Summers, Angela","van Dellen, David","Augustine, Titus","32457133"],"abstract":["COVID-19 is impacting provision of renal transplantation in the UK with a reduction in clinical activity. Publicly available Renal Registry and NHS Blood and Transplant reports were analysed to model the number of missed transplant opportunities, waiting list size and change in dialysis population over a six-month period starting 5 March 2020. An estimated 1,670 kidney transplant opportunities may be lost, which will lead to 6,317 active patients on the kidney-alone waiting list, compared to 4,649 based on usual activity estimates. This will result in 1,324 additional patients on dialysis who would otherwise have been transplanted. COVID-19 will lead to a marked loss of transplant opportunities and a significantly larger national waiting list. The existing strain on dialysis capacity will be exacerbated as patients remain on dialysis as the only available form of renal replacement therapy. These findings will help inform policy and service specific strategies."],"journal":"Clin Med (Lond)","authors":["Sharma, Videha","Shaw, Alex","Lowe, Marcus","Summers, Angela","van Dellen, David","Augustine, Titus"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32457133","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.7861/clinmed.2020-0183","keywords":["covid-19","nhs","kidney transplantation","renal insufficiency","renal replacement therapy"],"locations":["GBR","Transplant","GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1667967699035095040,"score":197.37253},{"pmid":32251003,"title":"Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.","text":["Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.","BACKGROUND: Critical patients with the 2019 coronavirus disease (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. METHODS: From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of >1 month and extremely high sequential organ failure assessment (SOFA) scores. RESULTS: Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. CONCLUSIONS: Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.","Chin Med J (Engl)","Chen, Jing-Yu","Qiao, Kun","Liu, Feng","Wu, Bo","Xu, Xin","Jiao, Guo-Qing","Lu, Rong-Guo","Li, Hui-Xing","Zhao, Jin","Huang, Jian","Yang, Yi","Lu, Xiao-Jie","Li, Jia-Shu","Jiang, Shu-Yun","Wang, Da-Peng","Hu, Chun-Xiao","Wang, Gui-Long","Huang, Dong-Xiao","Jiao, Guo-Hui","Wei, Dong","Ye, Shu-Gao","Huang, Jian-An","Zhou, Li","Zhang, Xiao-Qin","He, Jian-Xing","32251003"],"abstract":["BACKGROUND: Critical patients with the 2019 coronavirus disease (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. METHODS: From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of >1 month and extremely high sequential organ failure assessment (SOFA) scores. RESULTS: Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. CONCLUSIONS: Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained."],"journal":"Chin Med J (Engl)","authors":["Chen, Jing-Yu","Qiao, Kun","Liu, Feng","Wu, Bo","Xu, Xin","Jiao, Guo-Qing","Lu, Rong-Guo","Li, Hui-Xing","Zhao, Jin","Huang, Jian","Yang, Yi","Lu, Xiao-Jie","Li, Jia-Shu","Jiang, Shu-Yun","Wang, Da-Peng","Hu, Chun-Xiao","Wang, Gui-Long","Huang, Dong-Xiao","Jiao, Guo-Hui","Wei, Dong","Ye, Shu-Gao","Huang, Jian-An","Zhou, Li","Zhang, Xiao-Qin","He, Jian-Xing"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251003","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1097/CM9.0000000000000839","topics":["Treatment","Prevention"],"weight":1,"_version_":1666138491003600897,"score":195.74356},{"pmid":32454041,"title":"An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.","text":["An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.","BACKGROUND: The outbreak of Covid-19 has vastly increased the operational burden on healthcare systems worldwide. For patients with end-stage liver failure, liver transplantation is the only option. However, the strain on intensive care facilities caused by the pandemic is a major concern. There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources. METHODS: We performed an international multi-center study of transplant centers to understand the evolution of policies for transplant prioritization in response to the pandemic in March 2020. To describe the ethical tension arising in this setting, we propose a novel ethical framework, the Quadripartite Equipoise (QE) score, that is applicable to liver transplantation in the context of limited national resources. RESULTS: Seventeen large- and medium- sized liver transplant centers from twelve countries across four continents participated. Ten centers opted to limit transplant activity in response to the pandemic, favoring a \"sickest-first\" approach. Conversely, some larger centers opted to continue routine transplant activity in order to balance waiting list mortality. To model these and other ethical tensions, we computed a QE score using 4 factors - Recipient Outcome, Donor/Graft Safety, Waiting List Mortality and Healthcare Resources for seven countries. The fluctuation of the QE score over time accurately reflects the dynamic changes in the ethical tensions surrounding transplant activity in a pandemic. CONCLUSIONS: This four-dimensional model of Quadripartite Equipoise addresses the ethical tensions in the current pandemic. It serves as a universally applicable framework to guide regulation of transplant activity in response to the increasing burden on healthcare systems to allow greater global solidarity and transparency in these austere times.","J Hepatol","Chew, Claire Alexandra","Iyer, Shridhar Ganpathi","Chieh Kow, Alfred Wei","Madhavan, Krishnakumar","Teng Wong, Andrea Sze","Halazun, Karim J","Battula, Narendra","Scalera, Irene","Angelico, Roberta","Farid, Sharid","Buchholz, Bettina M","Rotellar, Fernando","Chi-Yan Chan, Albert","Kim, Jong Man","Wang, Chih-Chi","Pitchaimuthu, Maheswaran","Reddy, Mettu Srinivas","Soin, Arvinder Singh","Derosas, Carlos","Imventarza, Oscar","Isaac, John","Muiesan, Paolo","Mirza, Darius F","Bonney, Glenn Kunnath","32454041"],"abstract":["BACKGROUND: The outbreak of Covid-19 has vastly increased the operational burden on healthcare systems worldwide. For patients with end-stage liver failure, liver transplantation is the only option. However, the strain on intensive care facilities caused by the pandemic is a major concern. There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources. METHODS: We performed an international multi-center study of transplant centers to understand the evolution of policies for transplant prioritization in response to the pandemic in March 2020. To describe the ethical tension arising in this setting, we propose a novel ethical framework, the Quadripartite Equipoise (QE) score, that is applicable to liver transplantation in the context of limited national resources. RESULTS: Seventeen large- and medium- sized liver transplant centers from twelve countries across four continents participated. Ten centers opted to limit transplant activity in response to the pandemic, favoring a \"sickest-first\" approach. Conversely, some larger centers opted to continue routine transplant activity in order to balance waiting list mortality. To model these and other ethical tensions, we computed a QE score using 4 factors - Recipient Outcome, Donor/Graft Safety, Waiting List Mortality and Healthcare Resources for seven countries. The fluctuation of the QE score over time accurately reflects the dynamic changes in the ethical tensions surrounding transplant activity in a pandemic. CONCLUSIONS: This four-dimensional model of Quadripartite Equipoise addresses the ethical tensions in the current pandemic. It serves as a universally applicable framework to guide regulation of transplant activity in response to the increasing burden on healthcare systems to allow greater global solidarity and transparency in these austere times."],"journal":"J Hepatol","authors":["Chew, Claire Alexandra","Iyer, Shridhar Ganpathi","Chieh Kow, Alfred Wei","Madhavan, Krishnakumar","Teng Wong, Andrea Sze","Halazun, Karim J","Battula, Narendra","Scalera, Irene","Angelico, Roberta","Farid, Sharid","Buchholz, Bettina M","Rotellar, Fernando","Chi-Yan Chan, Albert","Kim, Jong Man","Wang, Chih-Chi","Pitchaimuthu, Maheswaran","Reddy, Mettu Srinivas","Soin, Arvinder Singh","Derosas, Carlos","Imventarza, Oscar","Isaac, John","Muiesan, Paolo","Mirza, Darius F","Bonney, Glenn Kunnath"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454041","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jhep.2020.05.023","keywords":["covid-19","equipoise","ethics","liver transplantation"],"topics":["Prevention"],"weight":1,"_version_":1667881798554615808,"score":194.2063}]}